Autoantibody reactive with three classes of RNA polymerases in sera from patients with systemic sclerosis
- PMID: 8473491
- PMCID: PMC288113
- DOI: 10.1172/JCI116343
Autoantibody reactive with three classes of RNA polymerases in sera from patients with systemic sclerosis
Abstract
We have identified a novel autoantibody reactive with all three classes of RNA polymerases, well-characterized nuclear enzymes, in sera from patients with systemic sclerosis (SSc). After incubation with [35S]methionine-labeled HeLa cell extracts, 14 of 275 SSc sera immunoprecipitated 12 or 14 proteins with similar molecular weights as those of several subunit proteins of eukaryotic RNA polymerases I, II, and III. Purified IgG from these two types of sera inhibited RNA transcription catalyzed by RNA polymerases I, II, and III in vitro. Immunoblot analysis using RNA polymerase-enriched fraction showed that the majority of these sera reacted with 42- or 25-kD protein. Anti-RNA polymerase antibody was highly specific to SSc, especially to diffuse cutaneous SSc. Clinical features associated with this antibody included a high frequency of heart and kidney involvement and a poor survival rate at 5 yr after first visit. These findings indicate that the autoantibody to three classes of RNA polymerases is a new marker for a unique subset of diffuse cutaneous SSc.
Similar articles
-
Autoantibodies to RNA polymerases recognize multiple subunits and demonstrate cross-reactivity with RNA polymerase complexes.Arthritis Rheum. 1999 Feb;42(2):275-84. doi: 10.1002/1529-0131(199902)42:2<275::AID-ANR9>3.0.CO;2-P. Arthritis Rheum. 1999. PMID: 10025921
-
Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.J Dermatol. 2010 Jan;37(1):42-53. doi: 10.1111/j.1346-8138.2009.00762.x. J Dermatol. 2010. PMID: 20175839 Review.
-
Characterization of antinucleolar antibody reactivity in patients with systemic sclerosis and their relatives.J Rheumatol. 1997 Mar;24(3):477-84. J Rheumatol. 1997. PMID: 9058652
-
Isolated pulmonary hypertension in systemic sclerosis with diffuse cutaneous involvement: association with serum anti-U3RNP antibody.J Rheumatol. 1996 Apr;23(4):639-42. J Rheumatol. 1996. PMID: 8730118
-
Serologic abnormalities in systemic sclerosis.Curr Opin Rheumatol. 1999 Nov;11(6):495-502. Curr Opin Rheumatol. 1999. PMID: 10551674 Review.
Cited by
-
Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers.Clin Rev Allergy Immunol. 2023 Jun;64(3):412-430. doi: 10.1007/s12016-022-08946-w. Epub 2022 Jun 18. Clin Rev Allergy Immunol. 2023. PMID: 35716254 Free PMC article.
-
B cell block: is rituximab a new possible treatment for systemic sclerosis?J Cell Commun Signal. 2010 Dec;4(4):201-2. doi: 10.1007/s12079-010-0107-x. Epub 2010 Nov 20. J Cell Commun Signal. 2010. PMID: 21234128 Free PMC article.
-
Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective.Ann Rheum Dis. 2019 Jul;78(7):879-889. doi: 10.1136/annrheumdis-2018-214436. Epub 2019 Mar 12. Ann Rheum Dis. 2019. PMID: 30862649 Free PMC article.
-
Anti-RNA polymerase III antibodies in patients with suspected and definite systemic sclerosis: Why and how to screen.J Scleroderma Relat Disord. 2018 Oct;3(3):214-220. doi: 10.1177/2397198318786158. Epub 2018 Jul 13. J Scleroderma Relat Disord. 2018. PMID: 35382018 Free PMC article. Review.
-
The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosis.Br J Dermatol. 2008 Mar;158(3):487-95. doi: 10.1111/j.1365-2133.2007.08392.x. Epub 2008 Jan 17. Br J Dermatol. 2008. PMID: 18205876 Free PMC article.